Journal profile · RHEUMATOLOGY
Modern Rheumatology
ISSN 1439-7595 · eISSN 1439-7609 · Springer Japan · Japan · Bimonthly · Founded 1997
Modern Rheumatology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.04; hybrid open access; APC about USD 3,208; median 88 days to acceptance (98 articles, last 24 months); community-reported acceptance: about 75%; 132 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Modern Rheumatology is published by Springer Japan and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Autoimmune and Inflammatory Disorders Research, together about 40.7% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Modern Rheumatology is the official journal of the Japan College of Rheumatology (JCR) and publishes original papers in English on research pertinent to rheumatology and associated areas such as pathology, physiology, clinical immunology, microbiology, biochemistry, experimental animal models, pharmacology, and orthopedic surgery. Occasional reviews of topics which may be of wide interest to the readership will be accepted. In addition, concise papers of special scientific importance that represent definitive and original studies will be considered. Letters should be limited to commentaries on previous articles published in Modern Rheumatology, subjects related to rheumatology, or topics of potential interest to members of the Japan College of Rheumatology. Rapid Communications should be very short reports of research findings, with no abstract. Other types of articles may be published at the discretion of the Editorial Board. Papers are welcomed from members of the Japan College of Rheumatology and non-members alike.
From the journal's Aims & Scope
Research area (LetPub): RHEUMATOLOGY
Editor-in-chief Masataka KuwanaPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine20.3%
- Systemic Lupus Erythematosus ResearchMedicine12.1%
- Autoimmune and Inflammatory Disorders ResearchMedicine8.4%
- Spondyloarthritis Studies and TreatmentsMedicine6.1%
- Vasculitis and related conditionsMedicine5.7%
- Systemic Sclerosis and Related DiseasesMedicine4.8%
- Inflammatory Myopathies and DermatomyositisMedicine3.8%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASPublisher website
Other: Google Scholar, EBSCO, OCLC
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.04LetPub ·
- Impact factor (publisher) 2025
- 4.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.3Publisher website ·
- CiteScore 2026-06
- 4.8LetPub ·
- CiteScore (publisher) 2025
- 25Publisher website ·
- SJR 2026-06
- 0.77LetPub ·
- SNIP 2026-06
- 0.95LetPub ·
- h-index
- 49LetPub ·
- h-index
- 87OpenAlex ·
- i10-index
- 2,375OpenAlex ·
- 2-year mean citedness
- 1.96OpenAlex ·
- Self-citation rate
- 9.5%LetPub ·
- Share of gold OA articles
- 28.36%LetPub ·
Volume
- Articles per year
- 122LetPub ·
- Downloads per year (publisher) 2025
- 276,318Publisher website ·
Articles by year OpenAlex count · 5,111 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 80 | 35 | 13 |
| 2025 | 132 | 62 | 201 |
| 2024 | 115 | 68 | 428 |
| 2023 | 118 | 54 | 722 |
| 2022 | 167 | 65 | 1,624 |
| 2021 | 193 | 44 | 1,988 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
88 daysMedian, submission to acceptance · P25–P75 59 days – 122 days
- Acceptance to online
- median 26 days (40 articles)
- Submission to online
- median 100 days
- Sample
- 98 articles with submission and acceptance dates (317 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1.5 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Submission to first decision 2025
- 37 daysPublisher website ·
- Submission to final decision 2025
- 47 daysPublisher website ·
- Acceptance to publication
- 15 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,208 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Japan
- Country or region
- Japan
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1997
- ISSN
- 1439-7595
- Electronic ISSN
- 1439-7609
- Society / sponsor
- Japan College of Rheumatology
- Latest issue on the website
- Volume 36, Issue 5 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Modern Rheumatology
What CAS zone is Modern Rheumatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Modern Rheumatology is in Zone 4 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Modern Rheumatology?
The latest impact factor listed by LetPub is 2.04; CiteScore 4.8, h-index 87.
How long does peer review take at Modern Rheumatology?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 88 days (interquartile range 59–122 days); authors report an average review time of about 1.5 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Modern Rheumatology?
According to LetPub and DOAJ records, Modern Rheumatology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase and CAS; that list has not been checked against each database.
Is Modern Rheumatology open access, and what is the APC?
Modern Rheumatology is a hybrid journal. For open-access publication: APC about USD 3,208.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .